These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35370729)

  • 1. Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease.
    Fang X; Wang H; Tan X; Ye T; Xu Y; Fan J
    Front Pharmacol; 2022; 13():840764. PubMed ID: 35370729
    [No Abstract]   [Full Text] [Related]  

  • 2. Association Between Circulating Regulator of Calcineurin 2 Concentrations With Overweight and Obesity.
    Wang H; Fang X; Ren Q; Zeng Y; Tan X; Ye T; Fan J; Xu Y
    Front Endocrinol (Lausanne); 2022; 13():857841. PubMed ID: 35733783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
    Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
    Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Serum Free Fatty Acids to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study.
    Zhang X; Lv Z; Zhang J; Zheng R; Dai Y; Qin J
    Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study.
    Fang X; Wang H; Ye T; Fu X; Tan X; Zeng Y; Fan J; Xu Y
    Lipids Health Dis; 2021 Aug; 20(1):96. PubMed ID: 34461919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
    Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.
    Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B
    BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
    Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
    World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    Erhartova D; Cahova M; Dankova H; Heczkova M; Mikova I; Sticova E; Spicak J; Seda O; Trunecka P
    PLoS One; 2019; 14(11):e0224820. PubMed ID: 31703079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels.
    Ma C; Liu Y; He S; Zeng J; Li P; Ma C; Ping F; Zhang H; Xu L; Li W; Li Y
    Front Endocrinol (Lausanne); 2020; 11():600472. PubMed ID: 33329401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
    Draijer LG; Feddouli S; Bohte AE; Vd Baan Slootweg O; Pels Rijcken TH; Benninga MA; Stoker J; Koot BGP
    Eur J Pediatr; 2019 Jun; 178(6):863-870. PubMed ID: 30903305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
    Yu Y; Chen D; Zhao Y; Zhu J; Dong X
    Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
    Arora A; Sharma P
    J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.